Retatrutide Tested for Liver Disease Outcomes in Major Clinical Trial | Retatrutide News

The SYNERGY-OUTCOMES trial is assessing retatrutide and tirzepatide for preventing liver disease outcomes in MASLD. The trial involves 4,500 adults and ...
Clinical Trials · October 22, 2026